share_log

Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Sanders Corazon (Corsee) D.

SEC ·  Jul 4, 2024 02:10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more